{"id":"W3015984203","doi":"10.1182/blood.2019004143","title":"Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Health Sciences Centre; Alberta Hospital Edmonton; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Astex Pharmaceuticals","keywords":"Decitabine; Medicine; Neutropenia; Chronic myelomonocytic leukemia; Febrile neutropenia; Internal medicine; Adverse effect; Confidence interval; Gastroenterology; Pharmacodynamics; Azacitidine; Pharmacology; Myelodysplastic syndromes; Pharmacokinetics; Toxicity; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007126293,0.0003135667,0.0009992449,0.0001271981,0.0001232604,0.0000656692,0.0001890375,0.00007703456,0.0005034677],"category_scores_gemma":[0.0008373312,0.0002526803,0.0002217111,0.0003468192,0.0001987749,0.0001189033,0.0001678637,0.0003813935,0.00004334972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004622868,"about_ca_system_score_gemma":0.000208155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003279107,"about_ca_topic_score_gemma":0.000001674917,"domain_scores_codex":[0.9977509,0.000173273,0.0005032788,0.0005849689,0.0004553701,0.0005321651],"domain_scores_gemma":[0.9984375,0.0004514809,0.0001029694,0.0002459211,0.0002130771,0.0005489989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6133375,0.009197854,0.001706226,0.000811353,0.003846629,0.001224211,0.00366764,0.00001344679,0.338134,0.0001338541,0.01965206,0.008275227],"study_design_scores_gemma":[0.9443718,0.002274045,0.0001624696,0.00002269855,0.002434674,0.00009395718,0.0002194528,0.02355047,0.02105541,0.00002700855,0.005509083,0.0002789759],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878331,0.0006986241,0.0009088281,0.004092116,0.00009523072,0.005488215,0.000114843,0.0001606772,0.0006083054],"genre_scores_gemma":[0.9947239,0.0001512673,0.001475781,0.001726738,0.0005886706,0.0005646193,0.00006854549,0.00008569576,0.0006148436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3310342,"threshold_uncertainty_score":0.9999925,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03744326903252199,"score_gpt":0.3788024146390228,"score_spread":0.3413591456065008,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}